The page is the record's research on the issuer — no analyst, no rating, no view. # Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Amylyx Pharmaceuticals, Inc., listed on NASDAQ under ticker AMLX, with ISIN US03237H1014. The LEI is not on the record. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted. ## The disclosure read The record holds 100 filings in the twelve months to 2026-11-08, on 45 filing days. The median gap between filing days is 5.0 days. The latest filing is a results filing dated 2026-11-05, 3 days before the record date. The exchange median is 6.0 days cadence, 52 filings and 5.0 days latency across 4,359 issuers. The sector median is 6.0 days cadence, 63.0 filings and 4.0 days latency across 526 issuers. By type, the record holds 3 AGM/EGM filings, 6 corporate news, 42 directors' dealings, 3 prospectuses, 38 regulatory filings and 8 results. ## Auditor The auditor is not on the record, because the latest annual report cover carries no auditor name tag. The auditor location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed annual years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001658551.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/AMLX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/AMLX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/AMLX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp